Cargando…

The Menstrual Cycle and Risk of Breast Cancer: A Review

Cyclic hormonal stimulation of the breast tissue plays a significant role in breast carcinogenesis. Current risk factor models do not include direct measures of cycle characteristics although the effects of possible surrogates of cycle activity such as age at menarche and menopause, parity, and nurs...

Descripción completa

Detalles Bibliográficos
Autores principales: Olsson, Håkan Lars, Olsson, Mona Landin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993118/
https://www.ncbi.nlm.nih.gov/pubmed/32038990
http://dx.doi.org/10.3389/fonc.2020.00021
_version_ 1783492966129598464
author Olsson, Håkan Lars
Olsson, Mona Landin
author_facet Olsson, Håkan Lars
Olsson, Mona Landin
author_sort Olsson, Håkan Lars
collection PubMed
description Cyclic hormonal stimulation of the breast tissue plays a significant role in breast carcinogenesis. Current risk factor models do not include direct measures of cycle characteristics although the effects of possible surrogates of cycle activity such as age at menarche and menopause, parity, and nursing time have been investigated. Future risk models should also include menstrual cycle length, regularity, number of cycles before first full-term pregnancy, and life-time number of cycles. New risk factor models for pre- and postmenopausal breast cancer are proposed here. Furthermore, there is a need for more long-term, prospective studies investigating menstrual cycle characteristics as data currently available are primarily retrospective and collected at one time-point only.
format Online
Article
Text
id pubmed-6993118
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-69931182020-02-07 The Menstrual Cycle and Risk of Breast Cancer: A Review Olsson, Håkan Lars Olsson, Mona Landin Front Oncol Oncology Cyclic hormonal stimulation of the breast tissue plays a significant role in breast carcinogenesis. Current risk factor models do not include direct measures of cycle characteristics although the effects of possible surrogates of cycle activity such as age at menarche and menopause, parity, and nursing time have been investigated. Future risk models should also include menstrual cycle length, regularity, number of cycles before first full-term pregnancy, and life-time number of cycles. New risk factor models for pre- and postmenopausal breast cancer are proposed here. Furthermore, there is a need for more long-term, prospective studies investigating menstrual cycle characteristics as data currently available are primarily retrospective and collected at one time-point only. Frontiers Media S.A. 2020-01-24 /pmc/articles/PMC6993118/ /pubmed/32038990 http://dx.doi.org/10.3389/fonc.2020.00021 Text en Copyright © 2020 Olsson and Olsson. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Olsson, Håkan Lars
Olsson, Mona Landin
The Menstrual Cycle and Risk of Breast Cancer: A Review
title The Menstrual Cycle and Risk of Breast Cancer: A Review
title_full The Menstrual Cycle and Risk of Breast Cancer: A Review
title_fullStr The Menstrual Cycle and Risk of Breast Cancer: A Review
title_full_unstemmed The Menstrual Cycle and Risk of Breast Cancer: A Review
title_short The Menstrual Cycle and Risk of Breast Cancer: A Review
title_sort menstrual cycle and risk of breast cancer: a review
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993118/
https://www.ncbi.nlm.nih.gov/pubmed/32038990
http://dx.doi.org/10.3389/fonc.2020.00021
work_keys_str_mv AT olssonhakanlars themenstrualcycleandriskofbreastcancerareview
AT olssonmonalandin themenstrualcycleandriskofbreastcancerareview
AT olssonhakanlars menstrualcycleandriskofbreastcancerareview
AT olssonmonalandin menstrualcycleandriskofbreastcancerareview